<DOC>
	<DOCNO>NCT01120028</DOCNO>
	<brief_summary>The 3C study investigate whether reduce exposure calcineurin inhibitor ( use potent antibody induction treatment and/or elective switch sirolimus ) improve function survival kidney transplant .</brief_summary>
	<brief_title>Campath , Calcineurin Inhibitor Reduction Chronic Allograft Nephropathy</brief_title>
	<detailed_description>The long-term survival kidney transplant improve past decade despite reduction rate acute rejection . The common cause late graft loss chronic allograft nephropathy frequently cause calcineurin inhibitor toxicity . Therefore , may possible improve long-term graft outcome reduce amount calcineurin inhibitor exposure . Two possible strategy test . Firstly , Campath-1H ( monoclonal lymphocyte-depleting antibody ) compare standard basiliximab-based induction . All patient receive tacrolimus-based maintenance therapy 6 month ( use low dos Campath-1H arm ) . At six month , patient re-randomised remain tacrolimus convert sirolimus ( therefore longer take calcineurin inhibitor ) . Patients followed-up clinic routine NHS registries collect information relevant outcome ( include graft function , survival , hospitalisation death ) .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Basiliximab</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Alemtuzumab</mesh_term>
	<criteria>men woman age 18 year recipient kidney transplant ( plan next 24 hour ) recipient multiorgan transplant previous treatment Campath1H active infection ( include HIV , hepatitis B C ) history anaphylaxis humanize monoclonal antibody history malignancy ( except adequately treat nonmelanoma skin cancer ) loss kidney transplant within 6 month due technical reason medical history might limit individual 's ability take trial treatment duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>